Deep Medicine Acquisition - Tradeable Rights - Oct 2026 Long Term Debt

Deep Medicine Acquisition - Tradeable Rights - Oct 2026 (DMAQR) currently reports a long-term debt of $140K as of June 2026. That compares with $880K in the prior-year period — down 84.5% year over year. Use the charts on this page to explore Deep Medicine Acquisition - Tradeable Rights - Oct 2026's long-term debt history and peer comparisons.

Deep Medicine Acquisition - Tradeable Rights - Oct 2026's long-term debt decreased from $880K to $140K — a 84.5% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Deep Medicine Acquisition - Tradeable Rights - Oct 2026 reported $140K in long-term debt as of June 2026. That compares with $880K in the prior-year period — down 84.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $140K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Deep Medicine Acquisition - Tradeable Rights - Oct 2026, and consider following DMAQR for alerts when major investors trade the stock.